Clinical Research Progress of Small Molecule Compounds Targeting Nrf2 for Treating Inflammation-Related Diseases

Clinical Research Progress of Small Molecule Compounds Targeting Nrf2 for Treating Inflammation-Related Diseases

Studies have found that inflammation is a symptom of various diseases, such as coronavirus disease 2019 (COVID-19) and rheumatoid arthritis (RA); it is also the source of other diseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), lupus erythematosus (LE), and liver damage. Nrf2 (nuc...

Full description

Bibliographic Details
Main Authors:	Zhenzhen Zhai, Yanxin Huang, Yawei Zhang, Lili Zhao, Wen Li
Format:	Article
Language:	English
Published:	MDPI AG 2022-08-01
Series:	Antioxidants
Subjects:	Nrf2 clinical research small molecule compounds inflammation-related diseases COVID-19 Alzheimer’s disease
Online Access:	https://www.mdpi.com/2076-3921/11/8/1564

Similar Items

A small-molecule inhibitor of Keap1–Nrf2 interaction attenuates sepsis by selectively augmenting the antibacterial defence of macrophages at infection sitesResearch in context
by: Yawei Wang, et al.
Published: (2023-04-01)

A New Nrf2 Inhibitor Enhances Chemotherapeutic Effects in Glioblastoma Cells Carrying p53 Mutations
by: Rayhaneh Afjei, et al.
Published: (2022-12-01)

Pharmacotherapy against Oxidative Stress in Chronic Kidney Disease: Promising Small Molecule Natural Products Targeting Nrf2-HO-1 Signaling
by: Md Jamal Uddin, et al.
Published: (2021-02-01)

The Role of Organosulfur Compounds as Nrf2 Activators and Their Antioxidant Effects
by: Melford Chuka Egbujor, et al.
Published: (2022-06-01)

Research Progress on Natural Small-Molecule Compounds for the Prevention and Treatment of Sepsis
by: Jingqian Su, et al.
Published: (2023-08-01)

Development of immunoassays for multi-residue detection of small molecule compounds
by: Xueyan Cui, et al.
Published: (2018-01-01)

Research Progress of Natural Small-Molecule Compounds Related to Tumor Differentiation
by: Xiaoli He, et al.
Published: (2022-03-01)

Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson's disease
by: Kai Zhang, et al.
Published: (2021-10-01)

Pharmacological Potential of Small Molecules for Treating Corneal Neovascularization
by: Zachary Barry, et al.
Published: (2020-07-01)

The Effect of Kaempferol on Autophagy and Nrf-2 Signaling in a Rat Model of Aβ1-42-induced Alzheimer’s Disease
by: Samira Rashtiani, et al.
Published: (2022-01-01)

Study on the Effect of Small Molecule Compounds on the Structure and Properties of Coal
by: Xiao Wang, et al.
Published: (2020-12-01)

Neuroglobin and neuroprotection: the role of natural and synthetic compounds in neuroglobin pharmacological induction
by: Lidia Ciccone, et al.
Published: (2021-01-01)

Contribution of the Nrf2 Pathway on Oxidative Damage and Mitochondrial Failure in Parkinson and Alzheimer’s Disease
by: Francisca Villavicencio Tejo, et al.
Published: (2021-07-01)

Small-molecule drugs development for Alzheimer's disease
by: Weiwei Yao, et al.
Published: (2022-11-01)

Small-Molecule Amyloid Beta-Aggregation Inhibitors in Alzheimer's Disease Drug Development
by: Sharmin Reza Chowdhury, et al.
Published: (2019-08-01)

Activators of Nrf2 to Counteract Neurodegenerative Diseases
by: Rosa Amoroso, et al.
Published: (2023-03-01)

Targeting SOST using a small-molecule compound retards breast cancer bone metastasis
by: Lisha Sun, et al.
Published: (2022-12-01)

A Pivotal Role of Nrf2 in Neurodegenerative Disorders: A New Way for Therapeutic Strategies
by: Sibel Suzen, et al.
Published: (2022-05-01)

An Overview of the Nrf2/ARE Pathway and Its Role in Neurodegenerative Diseases
by: Emilia Zgorzynska, et al.
Published: (2021-09-01)

Protection against Amyloid-β Oligomer Neurotoxicity by Small Molecules with Antioxidative Properties: Potential for the Prevention of Alzheimer’s Disease Dementia
by: Wataru Araki, et al.
Published: (2022-01-01)

Editorial: Role of Nrf2 in Disease: Novel Molecular Mechanisms and Therapeutic Approaches
by: Javier Egea, et al.
Published: (2019-10-01)

Development of dietary small molecules as multi-targeting treatment strategies for Alzheimer's disease
by: Rengasamy Balakrishnan, et al.
Published: (2024-05-01)

Inhibiting Cytoprotective Autophagy in Cancer Therapy: An Update on Pharmacological Small-Molecule Compounds
by: Lijuan Zhang, et al.
Published: (2022-08-01)

Food-Derived Pharmacological Modulators of the Nrf2/ARE Pathway: Their Role in the Treatment of Diseases
by: Feijie Zhao, et al.
Published: (2021-02-01)

Editorial: NRF2 signaling pathway: New insights in the field of reno-cardiovascular health
by: Zeba Farooqui, et al.
Published: (2023-04-01)

Antioxidant Efficacy of Hwangryunhaedok-tang through Nrf2 and AMPK Signaling Pathway against Neurological Disorders In Vivo and In Vitro
by: Su-Jin Bae, et al.
Published: (2024-02-01)

Editorial: Development of novel small molecules as therapeutics for inflammatory diseases and delineating their molecular mechanisms
by: Tharmarajan Ramprasath, et al.
Published: (2022-11-01)

When Neuroscience Meets Pharmacology: A Neuropharmacology Literature Analysis
by: Andy Wai Kan Yeung, et al.
Published: (2018-11-01)

Small-Molecule Inhibitors Targeting FEN1 for Cancer Therapy
by: Fan Yang, et al.
Published: (2022-07-01)

The Potential of Small Molecules to Modulate the Mitochondria–Endoplasmic Reticulum Interplay in Alzheimer’s Disease
by: Giacomo Dentoni, et al.
Published: (2022-08-01)

Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway
by: Yuyuan Yao, et al.
Published: (2022-11-01)

NRF2 deficiency replicates transcriptomic changes in Alzheimer's patients and worsens APP and TAU pathology
by: Ana I. Rojo, et al.
Published: (2017-10-01)

Therapies for Tau-associated neurodegenerative disorders: targeting molecules, synapses, and cells
by: Miranda Robbins
Published: (2023-01-01)

Structure-based virtual screening for the inhibition and clearance of amyloidosis by small molecules as pharmacological chaperones
by: Fantao Sun, et al.
Published: (2023-12-01)

Novel Cyclopentaquinoline and Acridine Analogs as Multifunctional, Potent Drug Candidates in Alzheimer’s Disease
by: Karolina Maciejewska, et al.
Published: (2022-05-01)

Moschus exerted protective activity against H2O2-induced cell injury in PC12 cells through regulating Nrf-2/ARE signaling pathways
by: Danni Xie, et al.
Published: (2023-03-01)

Activation of the Nrf2 Pathway Prevents Mitochondrial Dysfunction Induced by Caspase-3 Cleaved Tau: Implications for Alzheimer’s Disease
by: Francisca Villavicencio-Tejo, et al.
Published: (2022-03-01)

Regulated cell death in glioma: promising targets for natural small-molecule compounds
by: Mingyu Han, et al.
Published: (2024-01-01)

Review of Advanced Drug Trials Focusing on the Reduction of Brain Beta-Amyloid to Prevent and Treat Dementia
by: Decourt B, et al.
Published: (2022-10-01)

Small-molecule aggregation inhibitors reduce excess amyloid in a trisomy 16 mouse cortical cell line
by: ANDRÉA C PAULA LIMA, et al.
Published: (2008-01-01)